# A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

> **NCT00946569** · PHASE2 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 116 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** JNJ39758979
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00946569
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946569, "A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00946569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*